Efficacy of osimertinib in patients with EGFR mutant lung cancer harboring the uncommon exon 19 deletion, L747_A750>P Meeting Abstract
| Authors: | Grant, M. J.; Aredo, J. V.; Starrett, J.; Wurtz, A.; Piotrowska, Z.; Piper-Vallillo, A.; Yu, H. A.; Falcon, C.; Patil, T.; Nguyen, C.; Aggarwal, C.; Scholes, D. G.; Li, F.; Phadke, M.; Neal, J. W.; Walther, Z.; Politi, K. A.; Goldberg, S. B. |
| Abstract Title: | Efficacy of osimertinib in patients with EGFR mutant lung cancer harboring the uncommon exon 19 deletion, L747_A750>P |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680304358 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.e21112 |
| Notes: | Meeting Abstract: e21112 -- This meeting was also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
